REFERENCES
- Spits H, Lanier L L, Phillips J H. Development of human T and natural killer cells. Blood. 1995; 85: 2654–2670. [PUBMED], [INFOTRIEVE]
- Ichinohasama R, Endoh K, Ishizawa K, Okuda M, Kameoka J, Meguro K, Myers J, Kadin M E, Mori S, Sawai T. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin. Cancer. 1996; 77: 2592–2903. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Ino T, Tuzuki M, Okamoto M, Shamoto M, Hirano M. Acute leukemia with the phenotype of a natural killer/T cell bipotential precursor. Ann Hematol.. 1999; 78: 43–47. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Scott A A, Head D R, Kopecky K J, et al, HLA-DR−, CD33+, CD56+, CD16− myeloid/natural killer cell acute leukemia: a previously unrecognized from of acute leukemia potentially misdiagnosed as French–American–British acute myeloid leukemia-M3. Blood. 1994; 84: 244–255. [PUBMED], [INFOTRIEVE]
- Suzuki R, Yamamoto K, Seto M, et al, CD7 and CD56 myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. Blood. 1997; 90: 2417–2428. [PUBMED], [INFOTRIEVE]
- Ikushima S, Yoshihira T, Matsumura T, et al, Expression of CD56/NCAM on hematopoietic malignant cells: a useful marker for acute monocytic and megakaryocytic leukemias. Int J Hematol.. 1991; 54: 395–403. [PUBMED], [INFOTRIEVE]
- Wong K F, Chan J KC, Ng C S, Lee K C, Tsang WY W, Cheung HM C. CD56 (NKH-1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Human Pathol.. 1992; 23: 798–804
- Seymour J F, Pierce S A, Kantarjian H M, Keating M J, Estey E H. Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the natural cell adhesion molecule (CD56). Leukemia. 1994; 8: 823–826. [PUBMED], [INFOTRIEVE]
- Paietta E, Neuberg D, Richards S, et al, and the Eastern Cooperative Oncology Group. Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity. Am J Hematol.. 2001; 66: 189–196. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Brunning R D, Matutes E, Borowitz M, et al, Acute leukaemias of ambiguous lineage. Jaffe E S, Harris N L, Stein H, Vardiman J W. World Health Organization Classification of Tumours. Pathology and Genetic of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC Press. 2001; 106–107
- Uckun F M, Muraguchi A, Ledbetter J A, et al, Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood. 1989; 73: 1000–1015. [PUBMED], [INFOTRIEVE]
- Lenormand B, Vannier J P, Bene M C, et al, and the Groupe D'Etud Immunologique des Leucémies. CD2+ CD19+ acute lymphoblastic leukaemia in 16 children and adults: clinical and biological features. Br J Haematol.. 1993; 83: 580–583. [PUBMED], [INFOTRIEVE]
- Manabe A, Mori T, Ebihara Y, et al, Characterization of leukemic cells in CD2/CD19 double positive acute lymphoblastic leukemia. Int J Hematol.. 1998; 67: 45–52. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Fey M F, Tobler A, Stadelmann B, et al, Immunogenotyping with antigen receptor gene probes as a diagnostic tool in childhood acute lymphoblastic leukaemia. Eur J Haematol.. 1990; 45: 215–222. [PUBMED], [INFOTRIEVE]
- Reis M D, Griesser H, Mak T W. T cell receptor and immunoglobulin genes in hematologic malignancies. Tumor Biol.. 1990; 11(Suppl I)59–77
- Liang R, Chan V V, Chan T K, Chiu E, Todd D. Rearrangement of immunoglobulin and T cell receptor genes in acute and chronic leukaemias. Acta Haematol.. 1991; 85: 71–75. [PUBMED], [INFOTRIEVE]
- Breit T M, Wolvers-Tettero I LM, Beishuizen A, Verhoeven M-A J, van, Wering E R, van, Dongen J JM. Southern blot patterns, frequencies, and junctional diversity of T-cell receptor-δ gene rearrangements in acute lymphoblastic leukemia. Blood. 1993; 82: 3063–3074. [PUBMED], [INFOTRIEVE]